Nine Chapters Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-43,700
Closed -$839K 130
2017
Q1
$839K Buy
43,700
+5,400
+14% +$104K 1.13% 12
2016
Q4
$638K Buy
+38,300
New +$638K 1.08% 23
2013
Q4
Sell
-77,900
Closed -$1.83M 896
2013
Q3
$1.83M Buy
77,900
+61,700
+381% +$1.45M 0.21% 138
2013
Q2
$435K Buy
+16,200
New +$435K 0.08% 372